IL23A
Interleukin-23 subunit alpha
Also known as: IL-23, IL-23A, IL23A_HUMAN, IL23P19, P19, SGRF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPF7
- Gene
- IL23A
- Ensembl
- ENSG00000110944
- Chromosome
- 12
- Canonical length
- 189 aa
- Protein class
- FDA approved drug targets, Predicted secreted proteins
- Subcellular location
- Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a subunit of the heterodimeric cytokine interleukin 23 (IL23). IL23 is composed of this protein and the p40 subunit of interleukin 12 (IL12B). The receptor of IL23 is formed by the beta 1 subunit of IL12 (IL12RB1) and an IL23 specific subunit, IL23R. Both IL23 and IL12 can activate the transcription activator STAT4, and stimulate the production of interferon-gamma (IFNG). In contrast to IL12, which acts mainly on naive CD4(+) T cells, IL23 preferentially acts on memory CD4(+) T cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
189 residues, UniProt reviewed canonical sequence.
>Q9NPF7|IL23A
1 MLGSRAVMLL LLLPWTAQGR AVPGGSSPAW TQCQQLSQKL CTLAWSAHPL VGHMDLREEG
61 DEETTNDVPH IQCGDGCDPQ GLRDNSQFCL QRIHQGLIFY EKLLGSDIFT GEPSLLPDSP
121 VGQLHASLLG LSQLLQPEGH HWETQQIPSL SPSQPWQRLL LRFKILRSLQ AFVAVAARVF
181 AHGAATLSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL23A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 42 nTPM
- tonsil: 8.2 nTPM
- thymus: 6.7 nTPM
- esophagus: 4.3 nTPM
- testis: 4.2 nTPM
- lymph node: 4 nTPM
Single-cell type
- cdc: 55 nCPM
- epididymal basal cells: 55 nCPM
- late primary spermatocytes: 38 nCPM
- early primary spermatocytes: 35 nCPM
- innate lymphoid cells: 25 nCPM
- urothelial cells: 23 nCPM
Immune cell
- naive CD4 T-cell: 28 nTPM
- memory CD4 T-cell: 26 nTPM
- naive B-cell: 22 nTPM
- memory B-cell: 19 nTPM
- naive CD8 T-cell: 18 nTPM
- T-reg: 16 nTPM
Brain region
- hippocampal formation: 1.1 nTPM
- amygdala: 1 nTPM
- medulla oblongata: 1 nTPM
- thalamus: 1 nTPM
- white matter: 1 nTPM
- midbrain: 0.9 nTPM
ReferencesPubMed · IEDB
Publications for IL23A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice.
2012 · Arthritis Rheum · RCR 5.8 · 218 citations - IL-6-specific autoantibodies among APECED and thymoma patients.
2016 · Immun Inflamm Dis · RCR 1 · 31 citations - Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation.
2012 · Clin Exp Allergy · RCR 0.6 · 24 citations - [The IL-23p19 monoclonal antibody significantly alleviates nephritis in MRL/lpr lupus mice by modulating the Th17/Treg balance].
2025 · Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi - Rare pediatric Saccharomyces cerevisiae fungemia with neutralizing anti-IL-23 autoantibodies: a case report.
2026 · BMC Pediatr
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via JAK-STAT
- cell surface receptor signaling pathway via STAT
- defense response to Gram-negative bacterium
- defense response to virus
- inflammatory response
- innate immune response
- negative regulation of interleukin-10 production
- positive regulation of activated T cell proliferation
- positive regulation of defense response to virus by host
- positive regulation of granulocyte macrophage colony-stimulating factor production
- positive regulation of inflammatory response
- positive regulation of interleukin-10 production
- positive regulation of interleukin-12 production
- positive regulation of interleukin-17 production
- positive regulation of memory T cell differentiation
- positive regulation of natural killer cell activation
- positive regulation of natural killer cell proliferation
- positive regulation of neutrophil chemotaxis
- positive regulation of NK T cell activation
- positive regulation of NK T cell proliferation
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of osteoclast differentiation
- positive regulation of T cell mediated cytotoxicity
- positive regulation of T cell proliferation
- positive regulation of T-helper 1 type immune response
- positive regulation of T-helper 17 cell lineage commitment
- positive regulation of T-helper 17 type immune response
- positive regulation of tissue remodeling
- positive regulation of transcription by RNA polymerase II
- positive regulation of tumor necrosis factor production
- positive regulation of type II interferon production
- T cell proliferation
- tissue remodeling
Molecular functions
- cytokine activity
- interleukin-23 receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Four-helical cytokine-like, core
- Interleukin-23 alpha
- Interleukin 23 subunit alpha
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL23A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL23A as an antibody target. Whether an autoantibody or antibody against IL23A could matter depends on whether native IL23A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL23A is annotated as secreted, so native IL23A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL23A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...